The 6th edition of the Conference “Innovative Treatments in Oncology”
Date: 27 03 2020
Loc: Centrul de Excelenta in Medicina Translationala Fundeni din Bucuresti
Organizers: IC Fundeni si TARUS Media
TARUS Media and the Fundeni Clinical Institute in Bucharest have the pleasure of inviting you to the scientific event that will take place on March 27, 2020, between 08:30 and 18:00 and will be hosted by the Center of Excellence in Translational Medicine Fundeni, Bucharest.
Coordinators
Prof. Dr. Irinel POPESCU & Conf. Dr. Adina CROITORU
Lecturers
Dr. Vasile CEPOI, President of the National Authority for Quality Management in Health
Univ. Dr. Diana Loreta PAUN, Presidential Advisor – Department of Public Health
Prof. Dr. Tudor Eliade CIULEANU, Institute “Prof. Dr. I. Chiricuta ”, Cluj-Napoca
Prof. Dr. Mircea DEDIU, Sanador Oncology Center
Prof. Dr. Alfred HAIDENBERGER, Cyber-Knife Center, Munich
Prof. Dr. Domagoj JAVOR, Clinical Department of Interventional and Cardiovascular Radiology, AKH Vienna
Prof. Dr. Ioana LUPESCU, Fundeni Clinical Institute, Bucharest
Prof. Dr. Lucian MIRON, Regional Institute of Oncology in Iasi
Prof. Dr. Alina TANASE, Fundeni Clinical Institute, Bucharest
Conf. Dr. Serban NEGRU, Oncohelp Center, Timisoara
Conf. Dr. Dana-Lucia STANCULEANU, Institute of oncology “Prof. Dr. Al. Trestioreanu”, Bucharest
Dr. Simona DIMA, Fundeni Clinical Institute, Bucharest
Dr. Vlad HERLEA, Fundeni Clinical Institute, Bucharest
Dr. Dan JINGA, Neolife Medical Center, Bucharest
Dr. Laurentiu MICU, Fundeni Clinical Institute, Bucharest
Dr. Mariana MIHAILA, Fundeni Clinical Institute, Bucharest
Dr. Iulia SIMIONOV, Fundeni Clinical Institute, Bucharest
Topics:
Radiosurgery – Stereotactic radiotherapy guided by robotic images
How targeted are the targeted therapies actually?
The biology of malignant melanoma
Hematopoietic Stem Cell Transplantation in Multiple Myeloma in Romania – Patient Access to Standardized Treatment
The role of sectional imaging in the diagnosis of bile duct tumors
Bronchopulmonary cancers – mechanisms of resistance to systemic therapies: chemotherapy, targeted molecular therapies and immunotherapy
The current role of immunotherapy in the treatment of stage III nonresectable NSCLC
Participation:
FREE – for oncologists and related specialties
To register, access the Link: INREGISTRARE
Thank you!
Madalina CIULLEY – Event Project Manager
Tel: +40 745 624 635